Kaur, Deepinder

Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 620

Inducible Alterations of Glutathione Levels in Adult Dopaminergic Midbrain Neurons Result in Nigrostriatal Degeneration

Chinta, S. J., Kumar, M. J., Hsu, M., Rajagopalan, S., Kaur, D., Rane, A., Nicholls, D. G., Choi, J., & Andersen, J. K. (2007) · The Journal of Neuroscience

Parkinson's Disease Mechanisms and TreatmentsRedox biology and oxidative stress

Cited by 145

Does cellular iron dysregulation play a causative role in Parkinson’s disease?

Kaur, D., & Andersen, J. (2004) · Ageing Research Reviews

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 123

Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?

Kaur, D., & Andersen, J. K. (2002) · Aging Cell

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 44

Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration

Kaur, D., Rajagopalan, S., Chinta, S., Kumar, J., Di Monte, D., Cherny, R. A., & Andersen, J. K. (2007) · Brain Research

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 36